Hemosphere grabs $9.3M for vein access device
Hemosphere Inc. has raised more than $9.3 million in equity for its vascular access device that’s used by patients undergoing dialysis, according to a filing with the Securities and Exchange Commission. The company’s HeRo device is designed for use in patients with chronic kidney disease who’ve suffered damage to their veins. The device is implanted […]